News


25 - 36 of 134 items

Commission secures an agreement with Moderna to adapt delivery schedules to Member States' needs

Commission secures an agreement with Moderna to adapt delivery schedules to Member States' needs

Monday, 13 de June de 2022

The European Commission and the vaccine developer Moderna have reached an agreement to ensure that the delivery of COVID-19 vaccines is adapted to the needs of Member States. On the basis of this agreement, the company will postpone the delivery of some doses initially planned for quarter 2 of 2022, to later in the year. The agreement will also allow the delivery of vaccines adapted to future variants after approval by the European Medicines Agency, so that Member States can respond to any epidemiological developments later this year. 

Could we coat somebodys bones with metal to make them superstrong?

Could we coat somebodys bones with metal to make them superstrong?

Monday, 13 de June de 2022

Bones can be repaired and sometimes replaced with metal prostheses. So what’s stopping us reinforcing our skeletons? “Practically it is possible to coat a bone with metal, but a living bone will not survive. It needs the touch of its natural surroundings,” says Alisa Buchman. Bones need a healthy supply of blood, so they can absorb all the nutrients and oxygen they need, while expelling unwanted products like carbon dioxide, metabolic waste and acids.

Researchers Use AI to Predict Cancer Risk of Lung Nodules

Researchers Use AI to Predict Cancer Risk of Lung Nodules

Friday, 3 de June de 2022

An artificial intelligence (AI) tool helps doctors predict the cancer risk in lung nodules seen on CT, according to a new study published in the journal Radiology. AI can go through very large datasets to come up with unique patterns that can’t be seen through the naked eye and end up being predictive of malignancy. The model appears to work equally well on diagnostic CT and low-dose screening CT. 

AI Helps Diagnose Post-COVID Lung Problems

AI Helps Diagnose Post-COVID Lung Problems

Friday, 3 de June de 2022

A new computer-aided diagnostic tool developed by KAUST (King Abdullah University of Science & Technologym, Saudi Arabia) scientists could help overcome some of the challenges of monitoring lung health following viral infection. This new method known as Deep-Lung Parenchyma-Enhancing (DLPE) - overlays artificial intelligence algorithms on top of standard chest imaging data to reveal otherwise indiscernible visual features indicative of lung dysfunction.

Scientists shed light on a protein linked to diabetes and hypertension

Scientists shed light on a protein linked to diabetes and hypertension

Thursday, 2 de June de 2022

Combining a variety of techniques, EU-backed researchers have found what a sodium-proton exchanger called NHA2 looks like and how it works. Scientists have found that when these proteins do not work properly, they may lead to diseases such as cancer, diabetes, heart failure and hypertension. This discovery could lead to new drugs against high blood pressure and diabetes.

Mapping gene expression in two colours

Mapping gene expression in two colours

Monday, 23 de May de 2022

EU-backed researchers have used magnetic resonance imaging (MRI) to simultaneously track two different genes in two colours. The novel method could one day be used to monitor important processes deep in the body.

Coronavirus: Commission secures an agreement with BioNTech-Pfizer to adapt delivery schedules to Member States' needs

Coronavirus: Commission secures an agreement with BioNTech-Pfizer to adapt delivery schedules to Member States' needs

Tuesday, 17 de May de 2022

This will ensure Member States have access to the vaccines when they need them – including future variant adapted vaccines if authorised, so that they can respond to any epidemiological developments later this year and continue to support partner countries globally. This agreement with BioNTech-Pfizer will adapt the originally agreed contractual delivery schedules.

EMA starts review of cancer medicine Rubraca

EMA starts review of cancer medicine Rubraca

Thursday, 5 de May de 2022

EMA has started a review of the cancer medicine Rubraca (rucaparib camsylate) when it is used to treat cancer of the ovary, fallopian tubes or peritoneum with a BRCA mutation in patients whose cancer has come back after platinum-based chemotherapy and who can no longer have these medicines. The review follows preliminary results indicating that overall survival was shorter in these patients than in those receiving chemotherapy.

Commission calls on Member States to step up preparedness for the next pandemic phase

Commission calls on Member States to step up preparedness for the next pandemic phase

Wednesday, 4 de May de 2022

The Commission is today proposing a set of actions to manage the current phase of the COVID-19 pandemic and prepare for the next one.  In the new phase of the pandemic, where preparedness and response need to be sustained, coordination will be, once more, essential. The Commission therefore calls on Member States to take actions before autumn to ensure vigilance and continued coordination of health preparedness and response.

The interactive toolkit that helps healthcare facilities to control their waste management

The interactive toolkit that helps healthcare facilities to control their waste management

Monday, 2 de May de 2022

The set of six excel-based waste trackers, developed by Health Care Without Harm in consultation with strategic partner Health Environment and Climate Action Foundation, is designed to help healthcare facilities understand and control their waste management. Each one applies to a different stage of the waste management process, and they may be filled in by different people playing different roles in the system.

AI may Detect Earliest Signs of Pancreatic Cancer

AI may Detect Earliest Signs of Pancreatic Cancer

Monday, 2 de May de 2022

An artificial intelligence (AI) tool developed by Cedars-Sinai investigators accurately predicted who would develop pancreatic cancer based on what their CT scan images looked like years prior to being diagnosed with the disease. These findings may help prevent death through early detection of one of the most challenging cancers to treat.